Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice.

MLA

Šterzl, I., et al. “Patients with IgA Nephropathy Have Altered Levels of Immunomodulatory C19 Steroids. Glucocorticoid Therapy with Addition of Adrenal Androgens May Be the Choice.” Physiological Research, vol. 66, no. Suppl 3, Sept. 2017, pp. S433–42. EBSCOhost, https://doi.org/10.33549/physiolres.933732.

APA

Šterzl, I., Hill, M., Stárka, L., Velíková, M., Kančeva, R., Jemelková, J., Czerneková, L., Kosztyu, P., ZadraŽil, J., Matoušovic, K., Vondrák, K., & Raška, M. (2017). Patients with IgA nephropathy have altered levels of immunomodulatory C19 steroids. Glucocorticoid therapy with addition of adrenal androgens may be the choice. Physiological Research, 66(Suppl 3), S433–S442. https://doi.org/10.33549/physiolres.933732

Chicago

Šterzl, I, M Hill, L Stárka, M Velíková, R Kančeva, J Jemelková, L Czerneková, et al. 2017. “Patients with IgA Nephropathy Have Altered Levels of Immunomodulatory C19 Steroids. Glucocorticoid Therapy with Addition of Adrenal Androgens May Be the Choice.” Physiological Research 66 (Suppl 3): S433–42. doi:10.33549/physiolres.933732.